课题基金 / 基金详情

Role of pre- and postsynaptic mu opioid receptors in antinociception and tolerance

Role of pre- and postsynaptic mu opioid receptors in antinociception and tolerance
突触前和突触后μ阿片受体在镇痛和耐受中的作用
批准号:
9107437
负责人:
Susan L Ingram
金额:
$19.06万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2018-07-31

项目摘要

项目成果

Susan L Ingram的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):吗啡和其他阿片类药物是治疗疼痛的非常有效的治疗药物,但其抗伤害作用受到持续给药的有害副作用的限制,包括阿片类药物诱导的痛觉过敏、耐受性和依赖性。目前,美国每年花费超过86亿美元用于与处方阿片类药物的使用和滥用相关的健康,工作和法律的问题。这些副作用和阿片类药物诱导的突触可塑性的机制一直难以阐明,主要是因为我们对内源性疼痛控制系统如何被大脑激活和调节有初步的了解。已知中脑导水管周围灰质区(PAG)中GABA能末梢上的突触前μ阿片受体(MOPrs)激活下行的脊髓抗伤害感受通路。然而,MOPrs也大量表达在PAG神经元的索马和树突中,并且这些突触后受体的作用尚不清楚。我们推测,突触后MOPrs负责阿片耐受的适应。所提出的研究将使用siRNA构建体的体内给药,用突触后MOPrs的选择性敲低来检验这一假设。具体目标#1将测试突触后MOPrs的敲低是否减弱吗啡诱导的抗伤害感受。具体目标#2将确定是否可以在已经接受siRNA预处理的吗啡耐受大鼠中将抗伤害感受恢复到正常水平。我们期望这些研究将证实突触后MOPrs调节下行疼痛调节回路的增益,并且是镇痛治疗的适当靶点,其不会诱导有害的副作用,例如长期施用的痛觉过敏、耐受性和依赖性。这些研究还将为R01应用奠定基础,重点是了解内源性下行疼痛调节回路的突触后MOPr调节的分子机制。
英文摘要
 DESCRIPTION (provided by applicant): Morphine and other opioids are extremely effective therapeutic drugs for treating pain, but their antinociceptive effects are limited by detrimental side effects with continued administration, including opioid-induced hyperalgesia, tolerance and dependence. Currently, over $8.6 billion a year are spent in the U.S. for health, work, and legal issues associated with the use and abuse of prescription opioids. The mechanisms underlying these side effects and opioid-induced synaptic plasticity have been difficult to elucidate, primarily because we have a rudimentary understanding of how endogenous pain control systems are activated and regulated by the brain. It is known that presynaptic mu opioid receptors (MOPrs) on GABAergic terminals in the periaqueductal gray area (PAG) activate the descending antinociceptive pathway to the spinal cord. However, MOPrs are also abundantly expressed in the soma and dendrites of PAG neurons and the role of these postsynaptic receptors is not known. We hypothesize that the postsynaptic MOPrs are responsible for the adaptations in opioid tolerance. The proposed studies will test this hypothesis with selective knock-down of the postsynaptic MOPrs using in vivo administration of siRNA constructs. Specific Aim #1 will test whether knock-down of the postsynaptic MOPrs attenuates morphine-induced antinociception. Specific Aim #2 will determine if antinociception can be rescued to normal levels in morphine tolerant rats that have received the siRNA pretreatment. We expect that these studies will confirm that postsynaptic MOPrs regulate the gain of the descending pain modulatory circuit and are appropriate targets for analgesic therapies that do not induce detrimental side-effects such as hyperalgesia, tolerance and dependence with long-term administration. The studies will also lay the groundwork for an R01 application focused on understanding the molecular mechanisms of postsynaptic MOPr regulation of the endogenous descending pain modulatory circuit.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of lateral habenula in methamphetamine TAAR1-mediated synaptic plasticity and aversion
  • 批准号:
    10733665
  • 项目类别:
  • 资助金额:
    $56.56万
  • 财政年份:
    2023
  • 负责人:
    Susan L Ingram
  • 依托单位:
Dendritic DAT activity monitored with fluorescent biosensors
  • 批准号:
    7795252
  • 项目类别:
  • 资助金额:
    $31.09万
  • 财政年份:
    2008
  • 负责人:
    Susan L Ingram
  • 依托单位:
Dendritic DAT activity monitored with fluorescent biosensors
  • 批准号:
    7524822
  • 项目类别:
  • 资助金额:
    $31.15万
  • 财政年份:
    2008
  • 负责人:
    Susan L Ingram
  • 依托单位:
Dendritic DAT activity monitored with fluorescent biosensors
  • 批准号:
    7628408
  • 项目类别:
  • 资助金额:
    $30.52万
  • 财政年份:
    2008
  • 负责人:
    Susan L Ingram
  • 依托单位:
海外基金